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RNA interference (RNAi) was used to characterize the requirement of protein glycosylation for cell membrane stability
during cytokinesis in the early embryo. This screen targeted 13 enzymes or components of polypeptide sugar transferases
that initiate either N-glycosylation or three different pathways of O-glycosylation. RNAi of genes in the mucin-type and
epidermal growth factor-fringe glycosylation pathways did not affect cytokinesis. However, embryos deficient in N-
glycosylation exhibited a variable inability to complete cytokinesis. The most potent block in early embryonic cell
division was obtained by RNAi of the polypeptide xylose transferase (ppXyl-T), which is required to initiate the
proteoglycan modification pathway. Two generations of ppXyl-T RNAi-feeding treatment reduced the body size, mobil-
ity, brood size, and life span of adult animals. Embryos escaping ppXyl-T and Gal-T2 RNAi lethality develop to adulthood
but have cytokinesis-deficient offspring, suggesting that glycosyltransferases in the proteoglycan pathway are maternal
proteins in the early embryo. Gal-T2::GFP fusions and anti-Gal-T2 antibodies revealed a perinuclear staining pattern,
consistent with the localization of the Golgi apparatus. RNAi in green fluorescent protein (GFP)-tagged strains to follow
tubulin, PIE-1, and chromatin showed that deficient proteoglycan biosynthesis uncouples the stability of newly formed
cell membranes from cytokinesis, whereas cleavage furrow initiation, mitotic spindle function, karyokinesis, and
partitioning of intrinsic components are intact.
INTRODUCTION
Cell division, resulting in the formation of two separate
daughter cells from one parent cell, is a fundamental re-
quirement for embryonic development and animal life. The
later stages of cytokinesis require the coordination of two
well-characterized processes. First, a contractile ring of actin
and myosin pinches the parent cell, and second, a microtu-
bule network transports membrane vesicles to the cleavage
plane of the dividing cell. Vesicle delivery drives the forma-
tion of new cell membrane. Mutations in unc-60, an actin
depolymerizing factor, impair cytokinesis (Ono et al., 2003),
whereas suppression of either rab-11 or syn-4 genes, compo-
nents of the secretory pathway, results in late stage defects
in cytokinesis in Caenorhabditis elegans embryos—the cleav-
age furrow forms, but eventually regresses (Jantsch-Plunger
and Glotzer, 1999; Skop et al., 2001). The terminal phenotype
of mutations in unc-60, rab-11, and syn-4 is a multinucleated
embryo that continues karyokinesis in the absence of cyto-
kinesis. RAB11 is a GTPase that plays a role in receptor
recycling from the endosome to the plasma membrane, and
SYN4 is a syntaxin homologue implicated in intracellular
organelle and plasma membrane fusion. It has been hypoth-
esized that the mutations in the latter two genes suppress
vesicle trafficking, processes that are common to secretion.
On a similar theme, brefeldin A (BFA), a potent inhibitor of
secretion, blocks membrane vesicle budding, vesicle trans-
port and membrane accumulation at the cleavage plane and
also leads to a classic multinucleated phenotype, reflecting a
cytokinesis defect (Skop et al., 2001).
Membrane vesicles that are affected by these mutations
and drugs are potentially derived from an exocytosis path-
way or from the Golgi apparatus; therefore, this cytokinesis
defect may be the result of a deficiency in secreted and
membrane-bound molecules that are normally delivered to
the extracellular interface of newly dividing cells (Skop et al.,
2001). A great deal of emphasis has focused on the impor-
tance of membrane vesicle traffic, delivery, and fusion with
the plasma membrane (Straight and Field, 2000; Finger and
White, 2002), whereas less attention has been placed on the
potential cargo inside the vesicles that are delivered to the
interface of daughter cells. The contents of the vesicles and
their membrane protein components may be important for
the stabilization of newly formed membranes in the terminal
phase of cytokinesis.
Support for a stabilizing role of secreted material or mem-
brane-associated glycoproteins in cytokinesis mechanisms is
provided by studies of the sqv genes in C. elegans. Sqv-5 is
essential for cell division and has recently been shown by
two research groups to synthesize chondroitin, a precursor
for the carbohydrate polymers chondroitin sulfate and der-
matan sulfate (Hwang et al., 2003b; Mizuguchi et al., 2003).
Sqv-1 and sqv-4 genes are essential for the synthesis of
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UDP-xylose and sqv-7 transports multiple-nucleotide sugars
to the endoplasmic reticulum (ER)/Golgi. Null mutations in
sqv-1 and sqv-7 result in progeny that fail to initiate cytoki-
nesis (Hwang and Horvitz, 2002). These latter gene products
(SQV-1, SQV-4, and SQV-7) provide substrates for glycosyl-
ation reactions that posttranslationally modify diverse
classes of secreted and membrane-bound glycoconjugates.
To examine multiple protein glycosylation pathways, our
study reported here identified all the polypeptide sugar
transferases known in C. elegans and conducted an RNA
interference (RNAi) screen. Many of these genes have not
been examined in previous genome-wide RNAi studies.
Polypeptide sugar transferases are the key enzymes that
initiate specific protein glycosylation pathways by recogniz-
ing protein substrates and then modifying their amino acid
side chains with specific sugar residues. In C. elegans, the
glycosylation machinery is similar to that in mammals in
that nematodes express glycosyltransferase enzymes found
in both N-linked and O-linked glycosylation pathways (Ta-
ble 1). In this study, we used RNAi to examine the impact of
13 C. elegans glycosyltransferase genes on cytokinesis in the
developing C. elegans embryo. The penetrance of the RNAi
phenotype was dependent on the duration of RNAi treat-
ment. Continuous bacterial feeding RNAi for two genera-
tions permitted the analysis of maternal-effect lethal pheno-
types. Glycosyltransferases in the pathway that were most
critical for cytokinesis were cloned and expressed to validate
their function and to develop single-chain antibodies. Anti-
bodies and green fluorescent protein (GFP) reporter con-
structs were used to analyze the subcellular localization of
the glycosyltransferase and the properties of glycosyltrans-
ferase-deficient embryos.
MATERIALS AND METHODS
Cloning, Expression, and Purification of
Glycosyltransferases
cDNAs for C. elegans pXyl-T (Y50D4C.4) were amplified using PRIM-1
d[CGCGTCGCATATTTCGTCGGATAG] and PRIM-69 d[CTCCGGAGCG-
GCCGCTAAATCAAGGTCTGCGTATC]. An intact Gal-T2 cDNA was ob-
Table 1. RNA interference of C. elegans protein glycosylation pathways
Cosmid name
Gene
namea
Initiating enzyme
nameb
Modified
amino acid
Linked
sugar
Maximal % multinucleated eggsc
(polyploid in embryos)
N-Glycosylation, activity encoded by
genes for multiple subunits
T22D1.4 OST1, Ribophorin-I Asparagine GlcNAc 10 (20)
M01A10.3 SWP, Ribophorin-II Asparagine GlcNAc 10 (20)
O-glycosylation, proteoglycan-type. One
polypeptide xylose transferase gene
Y50D4C.4 sqv-6 Polypeptide xylose
transferase
Serine Xylose 100 (1)
O-glycosylation, EGF fringe-type. One
polypeptide fucose transferase gene
C15C7.7 Polypeptide fucose
transferase
Serine Fucose 0 (0)
O-Glycosylation, mucin-type. Nine
putative polypeptide GalNAc
transferase genes
ZK688.8 gly-3 Polypeptide GalNAc
transferase
Ser/Thr GalNAc 0 (0)
Y116F11B.12 gly-4 Polypeptide GalNAc
transferase
Ser/Thr GalNAc 0 (0)
Y39E4B.12 gly-5 Polypeptide GalNAc
transferase
Ser/Thr GalNAc 0 (0)
H38K22.5 gly-6 Polypeptide GalNAc
transferase
Ser/Thr GalNAc 0 (0)
Y46H3A.6 gly-7 Polypeptide GalNAc
transferase
Ser/Thr GalNAc 0 (0)
Y66A7A.6 gly-8 Polypeptide GalNAc
transferase
Ser/Thr GalNAc 0 (0)
Y47D3A.23 gly-9 Polypeptide GalNAc
transferase
Ser/Thr GalNAc 0 (0)
Y45F10D.3 gly-10 Polypeptide GalNAc
transferase
Ser/Thr GalNAc 0 (0)
Y75B8A.9 gly-11 Polypeptide GalNAc
transferase
Ser/Thr GalNAc 0 (0)
RNAi by gonad injection of dsRNA, only examined F1 generation.
a The following genes have not occurred in a previous genome-wide RNAi screens: gly-4, gly-5, gly-7, gly-9, gly-10, and gly-11. The Y50D4C.4
RNAi phenotype is reported as wild type by bacterial feeding; T22D1.4 has a low20–40% embryonic lethal RNAi phenotype that does not
describe the cytokinesis defect in the genome-wide study (Kamath et al., 2003).
b Enzymes initiate specific pathways of protein modification by scanning a protein substrate for a glycosylation site and then catalyzing the
transfer of a specific sugar to the protein side chain.
c The RNAi screen counted the number of multinucleated eggs that arrest in development at the one- to two-cell stage. Percentage in
parentheses indicates the percentage of F1 that have abnormal multinucleated cells. Values from the plate of F1 offspring with the highest
penetrance are shown.
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tained from the expressed sequence tag clone yk0292g2 and was amplified
with the primers PRIM-118 d[CGCGTCACCGCCAGCAACACCTTCAGC-
CATCA] and PRIM-143 d[GTGCGGCCGCTGGATTCTAATACGACT-
CACTATAGGG]. The soluble catalytic domains encoded by these cDNA
fragments were ligated into the MluI and NotI sites of pS2-MKF3c, an S2 cell
expression vector with a low copy origin of replication and a purification tag
sequence from pIMKF3 (Hagen and Nehrke, 1998).
The pS2-MKF3c vector uses a signal peptide to direct the secretion of
N-terminal purification (metal chelate and FLAG epitope) tags fused to the
cDNA coding regions, described above. Drosophila S2 Schneider cells were
cotransfected with pCo-BLAST and placed under blastocidin selection for
4–12 wk, as described by the supplier (DES system; Invitrogen, Carlsbad,
CA). Recombinant protein expression was induced from the metallothionein
promoter by adding 650 M copper sulfate. After 5 d, the culture media were
harvested and was buffer exchanged, using a 10-kDa molecular mass cut-off
membrane filter and a Pellicon tangential flow system (Millipore, Billerica,
MA). The secreted, recombinant protein was purified, using metal chelate
chromatography on Talon resin (BD Biosciences Clontech, Palo Alto, CA) and
anti-FLAG M1-agarose resin (Sigma, St. Louis, MO), using the protocols
recommended by the manufacturers. Protein yield and purity was deter-
mined by silver staining on SDS-PAGE and by Western blot analysis.
Anti-Gal-T2 Antibody Production
An antibody-phage display method was used to isolate recombinant antibod-
ies that bind to Y110A2AL.14, the C. elegans Gal-T2 protein. Recombinant
antibodies were obtained from a library of human single-chain variable
antibody fragments (scFv), fused to M13 gene III (Haidaris et al., 2001). A
panning procedure was used to enrich for tight-binding clones. Briefly, re-
combinant Gal-T2 was immobilized at a concentration of 10 to 50 g/ml in
Tris-buffered saline (TBS) to Nunc Immunoplates and then blocked in 0.5%
Blocker Reagent (Roche Diagnostics, Indianapolis, IN) in TBS. Then, 1012
human scFv antibody-phage was incubated with the immobilized antigen for
2 h at room temperature. Unbound phage was removed by washing with TBS
plus 0.5% Tween 20 (TBST). Bound phage was eluted in 50 l of freshly
prepared 100 mM glycine-HCl, pH 2.2, with 1 mg/ml bovine serum albumin
(BSA). Eluted phage was neutralized with 3 l of 2 M Tris-free base, trans-
duced into TG1 host cells, and infected with M13VCS helper phage to gen-
erate phage for the next enrichment. The panning protocol was repeated for
a total of three enrichments and individual clones of tight-binding phage were
identified by an enzyme-linked immunosorbent assay (ELISA). Positive
clones were treated with SalI and XhoI to delete the M13 gene III coat protein,
to produce soluble scFv proteins with an N-terminal FLAG epitope tag and a
C-terminal His6 tag. Anti-Gal-T2 scFv protein was produced by growing scFv
constructs under low phosphate conditions, and protein was purified from
the Escherichia coli host BL21 codon plus (Stratagene, La Jolla, CA) using
BugBuster (Novagen, Madison, WI) and metal chelate chromatography on
Talon resin (BD Biosciences Clontech). Final recombinant scFv protein was
dialyzed against 100 mM NaCl, 20 mM 2-(N-morpholino)ethanesulfonic acid
[MES], pH 6.5, and stored at –80°C. The anti-Gal-T2 scFv antibody works in
both ELISA and Western blot detection and is specific for the Gal-T2 protein
and not the fusion tag.
Detection and Localization of Gal-T2 Protein
To evaluate antibody specificity, the following protein preparations were
probed by Western blot: 1) 1–50 ng of recombinant Gal-T2 fused to a 38-aa
FLAG epitope-metal chelate tag; and 2) recombinant Gal-T2 cleaved from the
38-aa tag, using human rhinovirus 3c protease. For subcellular localization,
mixed stage N2 C. elegans nematodes were fixed and incubated with anti-
Gal-T2 antibodies. Briefly, worms and embryos were 1) fixed in fresh 4%
paraformaldehyde; 2) permeabilized at 4°C in 1% Triton X-100, 100 mM Tris,
pH 7.4; and 3) reduced at 37°C in 1% -mercaptoethanol, 1% Triton X-100, 100
mM Tris, pH 7.4, for 60 min at each step (Nonet et al., 1993). These specimens
were then treated with 10 mM NaBO3, 0.3% H2O2 for 1 h at room tempera-
ture, and then placed in Blocker solution (phosphate-buffered saline [PBS],
0.5% Triton X-100, 0.05% Na-azide, 1 mM EDTA, and 0.1% BSA) plus 1% BSA.
For antibody incubations, animals were washed in Blocker solution and were
treated sequentially with a series of antibodies: anti-Gal-T2 scFv antibody,
mouse anti-FLAG M2 antibody (Sigma), and a goat anti-mouse IgG antibody
(Molecular Probes, Eugene, OR), by incubating each antibody in Blocker
solution at 37°C for 1 h. Animals were mounted for microscopy with an equal
volume of Vectashield (Vector Laboratories, Burlingame, CA).
Gal-T2::GFP Reporter Constructs
Prim241 d[ACAAACACCCGCCTGTGCCTGTCAATCT] and Prim242 d[TT-
TAGCGCCACCCTGTCCCAGAAATGTTTCGGGAAGATTAGTTG] were
used to amplify Gal-T2 genomic sequences, which include 2.4 kb of 5 un-
translated region (UTR), exon 1, intron 1, part of exon 2, and the 18-nucleotide
(nt) PCR-fusion linker sequence. A GFP-encoding fragment was amplified
from pPD122.15, containing (from upstream to downstream end) an 18-nt
PCR fusion linker, GFP(S65C), four synthetic introns, and let-858 3UTR,
using primers Prim172 d[GGACAGGGTGGCGCTAAACAGGACCCAAA-
GGTATGTTTC] and Prim156 d[TACAGACAAGCTGTGACCGTCTCC]. The
Gal-T2 gene fragment was fused at amino acid 60 of Gal-T2 to the N terminus
of GFP, using the Expand 20-kb Plus PCR system (Roche Diagnostics),
Prim244 d[GGAGACTGCTATCAAGAATCGGTATGG], and Prim157 d[C-
GGGAGCTGCATGTGTCAGAGGTT]. This construction positioned GFP af-
ter the putative Golgi transmembrane anchor, targeting GFP to the lumen of
the Golgi. The Gal-T2::GFP reporter construct was coinjected with wild-type
pha-1 gene into the gonads of the worm strain GE24. Transgenic animals were
selected at 23°C.
Glycosyltransferase Assays
Recombinant glycosyltransferases were incubated at room temperature for
1–4 h in a 25-l reaction volume containing 25 mM MES, pH 6.5, 25 mM KCl,
5 mM KF, 5 mM MgCl2, and 5 mM MnCl2. For xylosyltransferase activity, the
following reaction substrates were added: UDP-[14C]xylose (20,000 cpm) and
the biotinylated peptide based on the human bikunin proteoglycan glycosyl-
ation site, NH2-GEEEGSGGGQKK(biotin)-COOH (Alpha Diagnostic, San An-
tonio, TX). To separate the radiolabeled glycopeptide reaction product, the
reaction was mixed with 25–50 l of an 1:1 slurry of streptavidin-agarose in
PBS and incubated for 30 min. The unincorporated label was washed from the
streptavidin beads two times, by adding 500 l of PBS, containing 0.1% Triton
X-100, and centrifuging the beads for 5 s at 5000 rpm in a Microfuge.
Substrates for galactosyltransferase assays include UDP-[14C]galactose and
various sugar acceptor analogues, chemically coupled to benzyl groups (Sug-
aris, Muenster, Germany). Galactosyltransferase reaction products were sep-
arated by anion exchange chromatography, using AG 1x8 resin (Bio-Rad,
Hercules, CA). Glycosyltransfer reaction controls to test for nucleotide sugar
hydrolysis included 1) assays in the absence of the sugar acceptor or 2) assays
that used Gal--biotin substrate and streptavidin-agarose separations. No
sugar-nucleotide hydrolysis was observed.
Worm Culture
Wild-type N2 and a RNAi hypersensitive mutant NL2099 were cultivated on
NGM agar plates seeded with OP50 E. coli. Animals were well fed on an OP50
food source for a minimum of two generations and never allowed to starve
before and during RNAi treatment. The following GPF-tagged nematode
strains were cultivated in an identical manner: AZ212 for histone::GFP,
WH204 for tubulin::GFP, and JH227 for Pie-1::GFP.
Microscopy
Animals were initially examined and scored, using a stereomicroscope. For
time-lapse microscopy, embryos were dissected from gravid adults, mounted
on an agar pad and imaged, using a Nikon E800 upright microscopy with
motorized shutters and Z-axis focus or an Axioplan 2 equipped with an
Axiocam (Carl Zeiss, Oberkochen, Germany). Time-lapse and Z-focus record-
ings were acquired every 20–30 s, using the SimplePCI software (Compix,
Cranberry Township, PA) and a SPOT2 digital camera.
RNA Interference Methods
Double-stranded RNA (dsRNA) Injection. Individual cDNAs (apx-1, GFP,
unc-54, Gal-T2, and ppXyl-T) were PCR amplified with primers that contain
T7 RNA polymerase promoter sites on the 5 end of both the upstream and
downstream primers. RNA was produced using 100 ng of the PCR product in
a 10-l in vitro transcription reaction using Megascript (Ambion, Austin, TX).
dsRNA was annealed by a 2-min 90°C denaturation step, followed by slow
cooling to 30°C over a 30-min period. The dsRNA was ethanol precipitated
and resuspended to a final concentration of 1–5 mg/ml. Young adults were
injected in a single gonad, and, after a 4- to 8-h recovery period, healthy adults
were transferred individually to fresh OP50 plates every 24 h for 3 d. The
embryonic lethality rate was calculated 12–14 h after the adult was removed
from the plate.
RNA Interference by Bacterial Feeding. Gal-T2, ppXyl-T, and unc-54 cDNAs
were cloned into the vector pPD128.36 (Timmons et al., 2001) and then
transferred to the E. coli strain HT115, which was grown to mid-log phase in
liquid culture, induced with 1 mM isopropyl -d-thiogalactoside (IPTG) for
1 h, and plated at a 5 concentration at 23°C for one night, either on
IPTG-NGM agar (Kamath et al., 2003) or on lactose plates. For lactose-induced
RNAi, lactose plates were prepared, containing 2% agar, 0.5% casamino acids,
0.2% lactose, 0.1% NH4Cl, 0.05% NaCl, 1 M9 buffer, 1 mM CaCl2, 0.0005%
cholesterol, and 200 g/ml ampicillin. Worms were seeded on the induced
lawn and incubated at 23°C. No more than four worms were added to any one
plate, or else the RNAi induction did not work. Animals were cultured for 1
to 2 d and transferred to fresh plates. F1 progeny that escaped lethality of
RNAi treatment were seeded on new RNAi plates for a second generation of
bacterial feeding.
Quantitative Reverse-Transcription PCR
Total RNA template was isolated from staged worm or embryo samples in
300 l of Tri Reagent and 2 l of polyacrylamide carrier (Molecular Research
Center, Cincinnati, OH). For RNAi-treated embryos, at least 20 embryos were
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used for RNA isolations. First-strand cDNA synthesis was conducted using
Super Script III (Invitrogen) in a final volume of 20 l, including either 2.5 g
of total RNA or RNA from an equivalent of 5 embryos. For PCR quantitation,
0.25 l of staged cDNA or 1 l of the 20-embryo cDNA preparation was used
as a template. PCR reactions were conducted in a Bio-Rad iCycler in 25-l
reactions, using 12.5 l of iQ-SYBR Green Super Mix and 0.4 M oligos. PCR
primers for Gal-T2 cDNA are Prim613 d[ATCCGAGATTTGATACCGAAT-
GGAGA] and Prim614 d[ACGTAGGATGGATGTTTTTGGAACTC]. PCR
primers for a cDNA control (ama-1) are Prim610 d[ACGTTGAAAAAGGTAA-
CATGCAATACA] and Prim612 d[GAAGCCATGGAGAGGTACGCGATA-
GAT]. At least one oligo in each pair was designed around splice junctions to
avoid genomic DNA contamination. All reactions were performed in tripli-
cate and a standard curve with a 4 or 5 log dilution series was used. Negative
controls, lacking templates, were included on all sample runs. The relative
copy number of the Gal-T2 template was normalized to either the total RNA
template concentration or the ama-1 template copy number. All experimental
values fell within the range of the standard curve.
RESULTS
RNAi Screen of the Major Protein Glycosylation
Pathways
An RNAi screen was used to determine which glycosylation
pathways are most critical for cytokinesis and preventing
cleavage furrow regression. The phenotypic readout of the
assay was the observation of multinucleated eggs or abnor-
mal polyploid cells in early embryos. This screen, therefore,
selects for glycosyltransferases that are essential for cell
membrane stability during cytokinesis in the early embryo,
whereas other cellular functions, such as mitotic spindle
formation and karyokinesis, are normal. During the course
of experiments, we found that the mode and duration of
dsRNA delivery had a great impact on the effectiveness of
RNAi treatment targeted against glycosyltransferase gene
products. Bacterial feeding RNAi was significantly more
effective with lactose plate dsRNA induction, compared
with the traditional IPTG plate induction. RNAi via injection
of dsRNA, although more labor-intensive, was more potent
in the F1 generation and thus used in the initial screen and
identification of critical glycosyltransferases.
To ensure that multiple protein glycosylation pathways
are addressed in an RNAi screen, we identified the key
glycosyltransferase genes in all known protein glycosylation
pathways that modify proteins in the secretory pathway,
either based on sequence similarity with known mammalian
glycosyltransferases or from nematode enzymes that have
been functionally expressed in previous reports. A total of 13
C. elegans glycosyltransferase gene products were targeted
for RNAi knockdown analysis (Table 1). Three genes in our
study (Y50D4C.4, M01A10.3, and T22D1.4) produced an em-
bryonic lethal phenotype by dsRNA injection, whereas a
previously published bacterial-feeding RNAi study includ-
ing these genes showed a weak or wild-type phenotype
(Kamath et al., 2003).
The first gene targets described in Table 1 include some of
the critical components of the oligosaccharyltransferase
(OST) complex, which initiates N-glycosylation. Little exper-
imental information has been reported on the N-glycosyla-
tion machinery in C. elegans. Protein N-glycosylation is ini-
tiated by a multiprotein, membrane-bound OST complex,
which scans for N-glycosylation sites on newly synthesized
proteins, during protein translation and translocation into
the endoplasmic reticulum. Protein sequence analysis sug-
gests that there are seven C. elegans candidate proteins that
either make up the OST complex or are involved with the
assembly of the complex. T22D1.4 encodes for a putative
586-aa type-1 membrane protein, representing the C. elegans
OST1/ribophorin-1 subunit, which is important for assem-
bly of the OST complex, is positioned close to the substrate
binding site, but it is not directly involved with substrate
recognition or catalysis (Yan and Lennarz, 2005). OST1 is
required for N-glycosylation in yeast and essential for via-
bility (Knauer and Lehle, 1999). RNAi of T22D1.4 resulted in
70% embryonic lethality, where development was arrested
at multiple stages (Table 1). Between 2 and 10% of the
arrested T22D1.4 RNAi-treated embryos exhibited a
multinucleated phenotype, a cytokinesis defect at the one- to
two-cell stage, whereas 20% of embryos arrested with some
polyploid cells. Another subunit of the OST complex is the
SWP protein, or ribophorin-II, which copurifies with OST1
from yeast and is required for full OST activity in yeast
(Knauer and Lehle, 1999). The C. elegans protein M01A10.3
has a membrane topology and sequence motif structure that
is identical to the yeast and mammalian SWP/ribophorin-II
protein (Krogh et al., 2001; Bateman et al., 2004). RNAi of C.
elegans ribophorin-II demonstrated a loss-of-function pheno-
type that was identical to that of ribophorin-I (Table 1). A
similar phenotype and penetrance (our unpublished data)
was observed for RNAi targeted at other subunits of the OST
complex, OST2/dad-1 and STT3, a subunit which plays a
critical role in catalysis of N-glycosylation in yeast (Yan and
Lennarz, 2005). In summary, our RNAi analysis of C. elegans
OST subunits showed a consistent cytokinesis defect that led
to a variable-stage developmental arrest, which was not
described in previous genome-wide RNAi screens.
To examine diverse protein O-glycosylation pathways in
the context of cytokinesis, gene targets for polypeptide sugar
transferases in the proteoglycan, epidermal growth factor
(EGF)-fringe, and mucin-type modification pathways were
identified. In contrast to N-glycosylation, polypeptide sugar
transferases in O-glycosylation pathways are monomeric
Golgi enzymes that scan proteins for specific amino acid
sequence motifs that define glycosylation sites and catalyze
the transfer of a specific monosaccharide to a serine or
threonine hydroxyamino acid in the motif. The initiating
enzymes in each of the three protein O-glycosylation path-
ways function independently, as a single enzyme species.
The first monosaccharide attached to the protein side chain
is unique for each modification pathway (xylose in proteo-
glycans, fucose in EGF repeats, and GalNac in mucin glyco-
proteins), and subsequently these attached monosaccharides
become substrates for downstream glycosyltransferases to
build oligosaccharide structures unique for each glycosyla-
tion pathway.
The RNAi screen, targeting 11 genes in O-glycosylation
pathways, demonstrated that early embryonic defects are
prevalent in embryos deficient in polypeptide xylose trans-
ferase (ppXyl-T), Y50D4C.4 (Table 1 and Figure 1). Only
some of the ppXyl-T RNAi-injected animals produced F1
progeny with a cytokinesis defect. For these affected animals
the initial brood was wild-type; however, when the multinu-
cleated phenotype occurred (2–3 d postinjection), most sib-
lings on the same plate shared the same cytokinesis defect.
Some F1 progeny escaped the ppXyl-T RNAi treatment;
however, at adulthood, they exhibited an egg-laying defect
and were bloated with multinucleated embryos (Figure 1D).
This maternal-effect phenotype is surprising because RNAi
is potent for depleting both maternal and zygotic mRNA.
The most plausible explanation for surviving ppXyl-T RNAi
F1 animals, carrying F2 embryos with a cytokinesis arrest, is
that the maternal component needed for the first cell divi-
sions in the early embryo is a protein (the glycosyltrans-
ferase enzyme) that is stored in oocytes. ppXyl-T (Y50D4C.4
or SQV-6) is the only C. elegans protein with sequence sim-
ilarity to the two human polypeptide xylose transferases
(Gotting et al., 2000; Hwang et al., 2003a); therefore, the
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Y50D4C.4-deficient embryos suggest that proteoglycan-type
modification is essential for early embryonic development.
To perform a similar loss-of-function analysis with EGF-
fringe protein glycosylation, RNAi was targeted to C15C7.7
gene, the only candidate polypeptide fucose transferase in C.
elegans. Polypeptide fucose transferase attaches fucose to
EGF repeats. Very little is known about EGF-fringe glyco-
sylation in nematodes, whereas in Drosophila EGF-fringe
glycosylation is essential for modulating notch receptor-
ligand interactions. Using dsRNA injection, C15C7.7
showed a wild-type phenotype in the context of cell division
in early embryos.
RNAi also was used to down-regulate enzymes that ini-
tiate mucin-type O-glycosylation. In contrast to proteogly-
can, EGF-fringe and N-glycosylation pathways, mucin-type
O-glycosylation is initiated by a large family of 13 indepen-
dent polypeptide GalNAc transferase isoforms. Eleven C.
elegans polypeptide GalNAc transferases have been ex-
pressed as recombinant proteins, and five of these isoforms
are functionally active with mammalian mucin peptide sub-
strates (Hagen and Nehrke, 1998). cDNA cloning and ge-
nome sequence analysis indicate that a total of 13 polypep-
tide GalNAc transferases are encoded by nine genes,
designated as gly-3, -4, -5, -6, -7, -8, -9, -10, and -11, in which
gly-5 and gly-6 are alternatively spliced into three isozymes,
each (Hagen et al., 2001). The size of the C. elegans polypep-
tide GalNAc transferase family is smaller than that of mam-
mals, which is predicted to include up to 24 members. RNAi
of the individual gly-3 through gly-11 genes did not result in
an early arrest in embryonic development (Table 1). It is
possible that gene redundancy may mask loss-of-function
phenotypes in our RNAi analysis. To address gene redun-
dancy issues, we injected more than one gly dsRNA at one
time, yet we did not observe an early embryonic arrest. In
addition, we used a transgene construct to express different
combinations of five to nine gly antisense RNAs at one time,
but we also did not observe an early embryonic arrest phe-
notype. It is possible that injection of mixtures of dsRNA or
expression of antisense RNA from transgenes has limited
effectiveness in the early embryo.
Cell Membrane Behavior in Early ppXyl-T-deficient
Embryos
To examine the loss-of-function phenotype of C. elegans
ppXyl-T in greater detail, the Y50D4C.4 mRNA was de-
pleted by RNAi and observed by time-lapse microscopy
(Figure 1). Time-lapse microscopy of ppXyl-T-deficient em-
bryos shows that the cleavage furrow forms but does not
progress to completion (Movies M1 and M2). Eventually,
these stalled cell membranes (in the cleavage plane) collapse
back to the cell membrane encompassing the embryo, as the
next round of nuclear division is initiated. As nuclear divi-
sions progress, the plasma membrane expands to fill the
entire eggshell. The properties of the plasma membrane or
the membrane–eggshell interactions seem to be altered, be-
cause ppXyl-T RNAi fertilized eggs filled out the eggshell
entirely, whereas in wild-type embryos there was a space,
especially in the anterior where the polar bodies were ex-
truded (compare Figures 1, A and B, and 2A). Time-lapse
microscopy also showed that membrane dynamics in the
anterior of the ppXyl-T-deficient embryos were different
from wild-type embryos. In wild-type embryos, plasma
membrane ruffling and blebbing is very active on the ante-
rior cell surface of the anterior embryo (the AB cell), which
develops transient ectopic cleavage furrows that were un-
productive and rapidly regressed into the original cell sur-
face. This transient membrane blebbing is normal in the
wild-type embryo, but it is exaggerated as more stable ec-
topic cleavage furrows in mel-11 mutants, which is a gene
that regulates the rate of nonmuscle myosin contractions,
involved in cleavage furrow progression (Piekny and Mains,
2002). In the ppXyl-T-deficient embryos, however, the tran-
sient membrane blebbing and ectopic cleavage furrow for-
mation on the anterior surface of the AB cell was completely
absent (Figures 1, A and B, and 2A and Movies M1 and M2).
The ppXyl-T RNAi treatment also rendered the embryos
susceptible to cell lysis, as the embryos easily disrupted
through the eggshell upon handling. Eggs laid by ppXyl-T
RNAi-treated adults also had a flattened appearance and
degraded rapidly on the agar plate. Collectively, the loss of
rounded cell shape and extracellular space and the disap-
pearance of normal membrane furrowing suggest that the
biosynthesis of proteoglycans support the cell membrane
structure and stabilize normal changes in cell shape during
cytokinesis.
Nuclear Divisions, Mitotic Spindles, and Partitioning in
ppXyl-T-deficient Embryos
To determine whether proteoglycans affect membrane–cy-
toskeleton interactions, the position of the spindle appara-
tus, and embryo polarity, we next examined the properties
of glycosyltransferase-deficient embryos, using GFP-tagged
marker proteins (Figure 2 and Movies M1 and M2). In
ppXyl-T RNAi-treated embryos, tagged with histone::GFP,
the timing of the first two rounds of nuclear divisions
seemed normal, even in the absence of complete cytokinesis
(Figure 2A). The cleavage plane and midbody were posi-
Figure 1. ppXyl-T RNAi impairs cytokinesis and leads to an egg-
laying defect, multinucleated embryos, and embryonic arrest. A
time-lapse panel demonstrates normal cell division in the early C.
elegans wild-type embryo (A) and the development of multinucle-
ated embryos after ppXyl-T RNAi treatment (B). (C) N2 oviduct and
uterus of a gravid wild-type adult. (D) ppXyl-T RNAi results in an
egg-laying defective adult, which is packed with multinucleated
embryos that exhibit defects in early embryo cytokinesis.
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tioned correctly in P0, to the posterior, such that the AB
daughter is larger than the P1 daughter. Cleavage furrow
formation initiated like normal. However, at the time cyto-
kinesis was nearly complete, daughter cell separation began
to collapse: the intracellular bridge along the cleavage plane
expanded and the cleavage furrow regressed. The second
round of nuclear divisions commenced with staggered tim-
ing, as expected in normal embryos (AB nuclei divides be-
fore P1). However, when the second round of cytokinesis
should have begun to form four cells, the remaining cell
membrane from the first cleavage plane began to diminish.
ppXyl-T RNAi of tubulin::GFP tagged embryos showed that
the spindle apparatus behaved normally, as, in most cases,
mitotic spindles were asymmetrically positioned at the first
nuclear division and karyokinesis progressed normally. The
P1 spindle rotated and set up normal perpendicular segre-
gation planes in the absence of new cell membrane (Figure
2B, top), but proper spindle orientation was not consistent,
because, in some cases, the chromosome segregation planes
were parallel for the AB and P1 cells (Figure 2A, 10). In
subsequent nuclear divisions, the centrosomes duplicated
normally, but because of the absence of cellularization, the
microtubules from different arrays interdigitated and many
nuclei eventually clumped in the center of the embryo (Fig-
ure 2B, bottom). Also, in normal embryos, an intact cell
membrane of AB daughter cells is required to allow one AB
daughter to slide anterior to its sister cell. After the second
round of nuclear divisions, in the ppXyl-T RNAi embryos,
the AB daughter nuclei divided across the embryo’s trans-
verse axis but did not reposition along the anterior-posterior
axis because separate AB daughter cells do not form and
slide past one another. As a result, the subsequent nuclear
positions were not normal in ppXyl-T-deficient embryos.
PIE-1::GFP embryos were used to determine whether the
polarity of the early embryo was lost upon failure to com-
plete cytokinesis in ppXyl-T-deficient embryos. Wild-type
embryos showed PIE-1::GFP concentrated in the posterior
nucleus in the P1 cell (Figure 2C, top), and, in later-stage
embryos, PIE-1 accumulation was retained in the P-lineage.
The polarity of this protein distribution was not lost in
ppXyl-T-deficient embryos. Even though cytokinesis failed
in ppXyl-T RNAi embryos, PIE-1::GFP accumulated in only
one nucleus, which was in the posterior embryo (Figure 2C,
middle and bottom). These results indicate that, although
the plasma membrane structure was affected in ppXyl-T
RNAi embryos, the spindle apparatus position, orientation,
and timing was normal most of the time and the embryo’s
polarity cues remained in place.
Analysis of Recombinant Glycosyltransferases from the
Proteoglycan Pathway
To determine whether glycosyltransferases were present in
the early embryo, we attempted to overexpress all glycosyl-
transferases in the proteoglycan biosynthesis pathway and
produce antibody probes. Recombinant ppXyl-T protein
was positive for xylose transferase activity, but the protein
yield was insufficient for an antibody screen. Antibodies
could only be produced for Gal-T2 (Y110A2AL.14), because
all other glycosyltransferases were refractory to expres-
sion. Gal-T2 adds the third sugar in the proteoglycan linker
tetrasaccharide (Figure 3). Y110A2AL.14 or SQV-2 is a
member of a large family of 21 C. elegans proteins with
sequence similarity to 1,3-galactosyltransferases; however,
Y110A2AL.14 has significantly higher sequence similarity
with mammalian Gal-T2 than with any other worm galac-
tosyltransferases, suggesting that there is only one nema-
tode gene that encodes for Gal-T2 activity.
To select for antibodies against a functional Gal-T2 pro-
tein, first a recombinant Y110A2AL.14 protein was ex-
pressed in high yield in Drosophila S2 insect cells and ex-
amined for enzyme activity, before antibody production.
Numerous sugar substrates were tested, because Y110A2AL.14
has significant amino acid sequence similarity with multiple
galactosyltransferases in different glycosylation pathways
(Figure 3, A and B). Although no transfer of galactose was
catalyzed to monosaccharide acceptor substrates ending
with GalNAc, GlcNAc, fucose, and xylose, Y110A2AL.14
protein did glycosylate Gal-terminating sugar analogues.
Higher activity was observed with an acceptor substrate that
had a galactose in a -linkage, suggesting that the enzyme
binds galactose substrates, but it is sensitive to configuration
of groups attached to galactose (Table 2). The highest rate of
transfer was observed for the substrate Gal-1,4-Xyl--Bz,
indicating that Y110A2AL.14 has approximately a 2000-fold
greater specificity for this xylose containing sugar, which is
a biosynthetic intermediate (see single-underlined sugars) of
the proteoglycan tetrasaccharide linker: GlcA-1,3-Gal-
1,3-Gal-1,4-Xyl-1-O-serine-(protein). The highly selec-
tive specificity of this recombinant protein indicated that
Y110A2AL.14 is Gal-T2, the galactosyltransferase that adds
the second galactose (see double underline) to tetrasaccha-
ride linker of proteoglycans: GlcA-Gal-Gal-Xyl-O-serine.
Furthermore, Y110A2AL.14 is only capable of galactose
transfer activity, as no transferase activity was detected with
Figure 2. ppXyl-T RNAi of embryos with GFP-tagged marker
proteins demonstrates normal spindle behavior and partitioning
properties at the first and second nuclear divisions. (A)
Histone::GFP shows normal karyokinesis and a normal initiation of
cytokinesis. The spindle is asymmetrically positioned (blue arrows).
When cytokinesis is nearly complete, the cleavage furrow begins to
regress (green arrows) and an intercellular bridge forms. The
daughter cells then loose their rounded shape, whereas the cleavage
furrow completely disappears (red arrows). Significantly more cell
membrane disappears from the cleavage plane, whereas the spindle
apparatus duplicates and begins to initiate the next round of nuclear
division. (B) tubulin::GFP shows that the spindle is actively dupli-
cating, migrating and initiating karyokinesis, in the absence of
proteoglycans in ppXyl-T RNAi-treated embryos. Centrosome du-
plication occurs and the microtubule arrays interdigitate (C)
PIE-1::GFP of a normal two-cell embryo (top) and in ppXyl-T RNAi-
treated embryos (bottom two panels). The PIE-1::GFP signal is
present in the most posterior nucleus. Embryos are orientated so
that anterior is to the left.
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other nucleotide sugars (Table 2). The observations, de-
scribed here, confirm and expand on the enzyme activities
reported on SQV-2 (Hwang et al., 2003a).
Kinetic analysis with the purified recombinant
Y110A2AL.14 protein provided a Km(UDP-Gal) value of 103
M and a Km(Gal-Xyl-Bz) of 180 M. Parallel assays run in
the presence of 5 mM Gal--Bz had no effect on either the Km
or Vmax, indicating that a related or pseudosubstrate, Gal-
-Bz, is not an effective competitive inhibitor of Gal-T2.
Therefore, cross-talk or pseudosubstrate inhibition with
other glycosylation pathways is likely to be rare, even
though numerous galactose-terminating oligosaccharide in-
termediates coexist in the Golgi apparatus and even though
the Y110A2AL.14 active-site is capable of docking with sim-
ple -linked and -linked galactose analogues. This func-
tional preparation of recombinant Gal-T2 was used to screen
a single-chain antibody library.
Localization of Proteoglycan Gal-T2 Enzyme in C. elegans
A single-chain Fv antibody (scFv) against Y110A2AL.14 pro-
tein was obtained from a library of 109 unique antibody-
phage. This antibody reacted both with the functional anti-
gen in ELISA and with the denatured antigen on a Western
blot. The anti-Gal-T2 scFv showed a strong immunofluores-
cence signal in all cells of early and late embryo specimens,
revealing numerous punctate organelles surrounding the
nucleus (Figure 4, A–C, and Movie M3). Nuclei were always
Figure 3. Y110A2AL.14/SQV-2 is a member of the 1,3 Gal-T family in C. elegans. (A) Amino acid sequence alignments of the sugar-donor
substrate-binding site of 21 putative C. elegans 1,3 Gal-T proteins and the human Gal-T2 protein. (B) Phylogenetic analysis based on this
catalytic domain, shown above. Annotations list the glycosylation pathway of the most closely conserved mammalian sequence homologue
for each worm gene. Type-1 oligos refers to type-1 Gal1,3GlcNAc-R oligosaccharides. The actual sugar structures that are synthesized by
most of these enzymes are not known, but they fall in a family of sugars with a 1,3-linkage. (C) Gal-T2 is in the proteoglycan biosynthesis
pathway. The pathway begins with an initiation reaction, the transfer of xylose to a serine residue in a proteoglycan, by ppXyl-T. A
tetrasaccharide linker (GlcA-Gal-Gal-Xyl-serine) is built through the sequential action of individual glycosyltransferases that add one sugar
at a time, after the xylose modification of peptide sequences has occurred. C. elegans Gal-T2 is encoded by Y110A2AL.14 or sqv-2 and is a
galactoslytransferase that specifically adds the third sugar residue in the linker tetrasaccharide. Gal-T1 and GlcA-T are encoded by the sqv-3
and sqv-8 genes, respectively. Glycosaminoglycan (GAG) chains chondroitin and heparan biosynthesis require the tetrasaccharide linker.
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devoid of fluorescence and the pattern of anti-Gal-T2 scFv
antibody fluorescence is similar to that seen with other
examples of worm Golgi proteins (Chen et al., 1999). There-
fore, anti-Gal-T2 antibody staining suggests that early em-
bryos are loaded with maternal Gal-T2 protein. The perinu-
clear staining pattern detected by the antibody was similar
to the detection of a Gal-T2::GFP transgene reporter, in
which the first 60 amino acids of Gal-T2 (including the
N-terminal transmembrane domain and stem region) was
fused to the N terminus of GFP. This reporter is designed to
replace the Gal-T2 catalytic domain with GFP (Figure 4, D
and E). The transgene reporter is expressed at a low level in
intestinal cells, showing diffuse staining that is concentrated
adjacent to the nucleus (Figure 4D).
To determine whether the antibody was against the
Gal-T2 protein and not the recombinant tags or putative N-
or O-glycan side chains, we used Western blot analysis
against recombinant and deglycosylated Gal-T2 protein
preparations (Figure 4F). ELISA and Western blot analysis
showed that the antibody recognized a recombinant Gal-T2
(31–330-aa) protein preparation, lacking the purification tags
(our unpublished data). Under nonreducing conditions in
SDS-PAGE, recombinant Gal-T2 migrates almost mainly as a
dimer (our unpublished data), whereas on a reducing dena-
turing gel Gal-T2 migrated as a 40-kDa monomer, with a
weak 76-kDa dimer band (Figure 4F). Sequence analysis
shows that Gal-T2 has two potential N-glycosylation sites
and a putative mucin domain in the stem region (position 31
–71), which has 46% serine  threonine  proline content.
Gal-T2 is itself a glycoprotein, as combined N-glycanase and
O-glycanase treatment resulted in a mobility shift (Figure
4F, lane 3 and 4). The formation of Gal-T2 dimers is consis-
tent with other galactosyltransferases (both 1,3 and 1,4
galactosyltransferases), which also form dimers (Yamaguchi
and Fukuda, 1995; Ju et al., 2002). The combined antibody
and GFP data support the interpretation that Gal-T2 is a
Golgi protein, localized in a perinuclear pattern in early
stage embryos.
First and Second Generation RNAi Knockdown
Phenotypes for Gal-T2
To further understand the loss-of-function phenotype of
glycosyltransferases in the proteoglycan pathway, Gal-T2
RNAi was performed for one or two generations. The F1
phenotype of Gal-T2 dsRNA injected animals was variable,
with many injection experiments yielding wild-type F1 em-
bryos. When multinucleated embryos occurred, a high per-
centage of the F1 siblings shared this lethal defect in cytoki-
nesis. This suggested that RNAi lowered the expression of
Gal-T2 mRNA or protein in some of the injected mothers to
a critical or lower threshold level before the lethal phenotype
predominated. Quantitative reverse transcription-PCR (Q-
RT-PCR) indicated that a 18-fold reduction in Gal-T2 mRNA
resulted in the arrested embryos relative to wild-type em-
bryos (Figure 5A). Q-RT-PCR of staged embryo and larval
preparations also showed that Gal-T2 is present at all stages
of development and up-regulated in early adulthood, dur-
ing egg laying (Figure 5B).
To deplete maternal and zygotic Gal-T2 mRNA and pro-
tein, RNAi treatment was extended for two generations, by
feeding with bacterial strains engineered to express Gal-T2
dsRNA. Lactose plates were used for RNAi treatments, be-
cause they were significantly more effective than IPTG plate
induction. Both the ppXyl-T and Gal-T2 RNAi feeding phe-
notypes were identical to each other (Figure 5, C, D, and F).
On lactose plates, bacterial feeding RNAi produced a strong
phenotype; however, lactose feeding plate phenotypes were
not as variable as seen with the injected animals. The P0
animals, fed on Gal-T2 lactose-RNAi plates, seemed normal
and produced viable F1 offspring, regardless of whether the
P0 were seeded on RNAi plates as L1 or L4 larva. Typically,
RNAi feeding of L1 larva is sufficient for depletion of adult
mRNA, whereas RNAi feeding of L4 larva has an immediate
knockdown of early embryonic mRNA. Embryonic arrest
was virtually absent in the F1 generation from P0 RNAi
animals. However, when these RNAi-treated F1 offspring
were transferred to fresh RNAi lactose plates (for a second
generation of RNAi feeding), they developed to F1 adults
that fed well, exhibiting strong pharyngeal pumping, but
did not move. These F1 adults were small, clear, and slightly
egg-laying defective, with a uterus bloated with embryos.
Greater than half of F1 adults had their uterus completely
filled with cytokinesis-deficient embryos of various sizes
(Figure 5D). Nearly 100% of the F2 embryos laid by these
adults also lacked cell membranes and had unusual egg
shapes. Therefore, either RNAi depletes maternal Gal-T2
Table 2. Y110A2AL.14 protein exhibits proteoglycan Gal-T2 activity
Sugar donor  Acceptor 7 nt  Glycosylated product
Reaction rate
(pmol/h)a
10 M 5 mM
UDP-Gal  GalNAc--Bz 7 No product 0
UDP-Gal  GalNAc--Bz 7 No product 0
UDP-Gal  GlcNAc--Bz 7 No product 0
UDP-Gal  GlcNAc--Bz 7 No product 0
UDP-Gal  Fuc--Bz 7 No product 0
UDP-Gal  Xyl--Bz 7 No product 0
UDP-Gal  Gal--Bz 7 UDP  Gal-*-Gal--Bz 1.6
UDP-Gal  Gal--Bz 7 UDP  Gal-*-Gal--Bz 3.6
UDP-Gal  Gal-1,4-Xyl--Bz 7 UDP  Gal-*-Gal-1,4-Xyl--Bz 7120
UDP-glucose  Gal-1,4-Xyl--Bz 7 No product 0
UDP-xylose  Gal-1,4-Xyl--Bz 7 No product 0
UDP-GalNAc  Gal-1,4-Xyl--Bz 7 No product 0
Proteoglycan
tetrasaccharide linker
GlcA-1,3-Gal-1,3-Gal-1,4-Xyl-1-O-serine-(protein)
a All reaction rates reflect the activity of 7.8 pmol of pure recombinant Y110A2AL.14 protein.
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protein after a sufficient period of RNA degradation or the
RNA degradation phenomenon increases in amplitude after
extensive RNAi treatment.
To examine the Gal-T2 RNAi phenotype for nuclear divi-
sion in the absence of cytokinesis (the cytokinesis defect), F2
embryos were treated for 2 min with the fluorescent dye
DAPI, which does not penetrate normal embryo mem-
branes. These DAPI-treated F2 embryos were permeable,
staining positive for multiple nuclei, suggesting a deficiency
both in the eggshell and cell membranes. Although no new
cell membranes formed, nuclei continued to divide for four
or five rounds of division, because typically20 nuclei were
present in the arrested embryos (Figure 5E). Nuclei clumped
together in one or more locations, which only occurs when
the cellularization is absent. This Gal-T2 RNAi feeding phe-
notype is essentially identical to the phenotype observed for
ppXyl-T in histone::GFP tagged animals (Figure 2A). Al-
though multinucleated embryos were visible on the Gal-T2
RNAi lactose plate by differential interference contrast (DIC)
or brightfield microscopy (Figure 5F), most of these embryos
rapidly lost their multinucleated appearance and began to
degrade, resulting in embryos looking like those in Figure
5, E and G. DIC microscopic examination of the F1 adults
from second generation feeding also showed that many
embryos were fertilized in utero, but began degrading
before being laid. F1 adults had a very short life span,
because all second generation RNAi-treated animals died
prematurely at 6 d postfertilization. Wild-type animals
and first generation RNAi-treated animals had a normal
life span, 2 wk.
Figure 4. Gal-T2 localization and detection in C. elegans. (A) Anti-Gal-T2 scFv antibody staining alone (top) or with DAPI nuclear
counterstain (bottom) in an eight-cell embryo. (B) High magnification of Golgi apparatus staining and nuclei from embryo in A. (C)
Anti-Gal-T2 scFv antibody staining in a 28-cell embryo shows perinuclear staining pattern. (D) GFP fluorescence staining and DIC of
intestinal cells from transgenic animals expressing a fusion of the N terminus and stem of Gal-T2 (1–60 aa) to a GFP reporter. Two nuclei
are present in the GFP-positive cell. The GFP fluorescence surrounds the left nucleus and forms a patch next to the right nucleus. The nuclei
themselves do not exhibit a GFP signal. (E) Structure and design of the wild-type Gal-T2 gene and the Gal-T2 stem::GFP reporter. GFP is fused
to amino acid codon 60 in the second exon, such that GFP replaces the C-terminal catalytic domain of Gal-T2. (F) Western blot detection of
Gal-T2 with anti-Gal-T2 scFv antibody. Lanes 1 and 2, 50 and 20 ng of recombinant Gal-T2, lacking the N-terminal transmembrane domain.
In place of the transmembrane domain, a 38-amino acid purification tag is genetically fused to the stem and catalytic domain of Gal-T2 (see
Materials and Methods for details). Lanes 3 and 4, 40 and 15 ng of recombinant Gal-T2 after peptide:N-glycanase and O-glycanase treatment.
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A second generation of bacterial feeding RNAi treatment
also was evaluated on IPTG plates, because this is the tra-
ditional method used in genome-wide screens. IPTG-induc-
tion of RNAi, however, led to only a 54% embryonic arrest
rate in F2 offspring. The first or second generation lethality
rates on IPTG plates did not increase with the use of an
RNAi hypersensitive rrf-3 mutant strain (our unpublished
data). Furthermore, the IPTG-induced phenotype had lower
penetrance, as embryos exhibited different sizes and shapes,
relative to wild-type controls, but arrested at different stages
of development (Figure 5, G and H). Among those F2 that
did hatch, significant abnormalities in body morphology
were apparent, primarily a shorter body plan or a Nob (no
backside) phenotype (Figure 5H). This intermediate pheno-
type, therefore, provides a means to study the requirement
of proteoglycans at later stages of development.
DISCUSSION
The majority of the genes that initiate protein glycosylation
reactions do not seem to be essential for the completion of
cytokinesis. Genes in the proteoglycan biosynthesis pathway
seem to have a unique role in early embryo cytokinesis.
RNAi knockdown of ppXyl-T or Gal-T2 resulted in a cyto-
kinesis defect, which seemed identical to strong mutations
in the chondroitin synthase gene sqv-5 (Hwang et al., 2003b;
Mizuguchi et al., 2003). Embryos and animals that escaped
one or two generations of ppXyl-T or Gal-T2 RNAi treat-
ment exhibited later stage embryonic arrest, abnormal larva,
and adult anatomy and premature death, which is similar to
a heparan synthase rib-2 null phenotype (Morio et al., 2003).
Therefore, depletion of the proteoglycan linker tetrasaccha-
ride (through ppXyl-T and Gal-T2 RNAi) will impact post-
translational modification of both chondroitin and heparan
proteoglycans. By comparing different RNAi methodologies
on the glycosyltransferases in this study, it is clear that
genome-wide RNAi screen studies need to be interpreted
with caution because the traditional RNAi methodology
(RNAi induction with IPTG plates for a single generation)
did not produce a potent knockdown of glycosyltrans-
ferases.
The cytokinesis defect in ppXyl-T-deficient embryos was
very specific. Early embryonic blast cells were able to initiate
cytokinesis. However, at the terminal phase of cytokinesis,
Figure 5. Gal-T2 depletion impairs embry-
onic development. (A) Quantitative reverse
transcription-PCR on wild-type and Gal-T2
RNAi-treated embryos shows a 18-fold re-
duction in Gal-T2 mRNA. RNA levels from
20 embryos in the two preparations are nor-
malized against an ama-1 control mRNA. (B)
Q-RT-PCR of Gal-T2 message from the fol-
lowing staged C. elegans RNA preparations:
oocytes, embryos, day 1 (L1) larva, day 2
(L2/L3) larva, day 3 (L4 larva and young
adults), and day 4 (gravid adults). Identical
quantities of total RNA from each staged
preparation are used in Quantitative RT-PCR.
(C–F) Induction of Gal-T2 RNAi on lactose
plates. (G and H) Induction of Gal-T2 RNAi
on IPTG plates. (C) Bacterial feeding RNAi at
23°C on lactose plates for two generations.
Cytokinesis defects were examined in the em-
bryos laid on the plate and also while em-
bryos were still in the uterus of gravid adults.
(D) The uterus of three gravid adults from
first generation Gal-T2 lactose-induced RNAi
plates show multi-nucleated embryos, varia-
tion in egg size, and degrading embryos. (E)
Embryos from second generation Gal-T2 lac-
tose-induced RNAi plates. Bottom, DIC of the
most common embryos after two generations
of RNAi. Top, DAPI staining of nuclei. Mid-
dle, merges the DAPI stain (converted to
black) over the DIC image. (F) Multinucle-
ated embryos from second generation of
RNAi feeding on lactose plates are deficient
in cytokinesis. After a few hours, these
multinucleated embryos begin to degrade
and resemble embryos shown in Figure 4, E
and G. (G) Egg size and shape defects and
embryonic arrest in second generation of
Gal-T2 RNAi treatment on IPTG plates. (H)
Gal-T2 RNAi also produces partially devel-
oped embryos and larva, displaying a short-
ened or NOB (no backside) phenotype on
IPTG plates.
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cell membrane formation at the daughter-cell interface
stalled and retracted, and the cells were flattened against the
eggshell and lost their normal shape. It is possible that
membrane vesicle transport on the spindle is still intact,
because, in ppXyl-T RNAi-treated embryos, the spindle po-
sition, migration and rotation are normal for a few nuclear
divisions (Figure 2). Furthermore, such cytokinesis-deficient
embryos exhibited no defects in embryo polarity with re-
spect to PIE-1 protein distribution. This ppXyl-T loss-of-
function phenotype seemed similar to a brefeldin A-induced
block in vesicle transport in C. elegans embryos, suggesting
that the brefeldin A phenotype could be the result of block-
ing the delivery of proteoglycans to the membrane interface
of newly dividing cells. (Skop et al., 2001).
Our initial RNAi screen probed multiple protein glycosyl-
ation pathways. When embryos were deficient in N-glyco-
sylation machinery, cytokinesis also was impaired; however,
the embryonic arrest phenotype was variable and less spe-
cific to cytokinesis. Inconsistent defects in N-glycosylation-
deficient embryos are probably of pleiotrophic or secondary
origin, because N-linked glycans are required for chaperone-
assisted folding of large numbers of different structural pro-
teins, enzymes and transporters. Therefore, an N-glycan-
deficiency may indirectly impair proteoglycans, because
most enzymes in the proteoglycan biosynthetic pathway are
themselves N-linked glycoproteins.
It is not clear whether the proteoglycan-dependent termi-
nal phase of cytokinesis is a generalized process that applies
to all higher eukaryotic cell division events. Even in C.
elegans, the multinucleated embryonic phenotype is primar-
ily observed in the early embryo at the first or second cell
cleavage, and rarely later. We did not detect significant
occurrences of multinucleated cells after the four-cell stage.
Also, the GAG chain chondroitin is present in fertilized eggs
but is not specifically localized to cleavage furrows or to the
newly dividing membrane plane (Mizuguchi et al., 2003).
Therefore, it is likely that chondroitin may mediate overall
cell membrane–extracellular matrix interactions to stabilize
cell shape, which is important for forming a stable interface
between newly dividing cells in the very early embryo. At
later developmental stages, it is possible that cells recruit
different species and classes of glycoproteins to stabilize
existing cell membrane integrity, shape, attachment as well
as stabilize newly forming cell membranes in daughter-cell
cleavage planes. In mammals, glycoproteins are expressed
in the cleavage plane of dividing cells, in a tissue and stage-
specific manner. For example, some human leukocytes ex-
press and recruit the mucin glycoprotein CD43 at the cleav-
age furrow during cell division (Yonemura et al., 1993). Each
CD43 molecule is a heavily glycosylated integral membrane
protein with up to 90 mucin-type oligosaccharide chains on
its extracellular domain. Mucin glycosylation may be impor-
tant for cell division in some human leukocytes; however,
there is no obvious role known for mucin glycosylation in
the early C. elegans embryo, because RNAi of the nine
polypeptide GalNAc transferases (ppGaNTases) did not re-
veal any cytokinesis defects or early embryonic arrest (Table
1). However, a role for these ppGaNTases in cell division
may be masked by redundant isoforms that could be coex-
pressed in the embryo or gonads.
In summary, the terminal phase of cytokinesis in the early
C. elegans embryo has a unique requirement for proteogly-
can modification of the cell surface. This observation is
consistent with the recent reports on the sqv-5 gene, which
indicates that an essential component of newly dividing cells
is the extracellular matrix glycosaminoglycan chondroitin
(Hwang et al., 2003b; Sugahara et al., 2003). To gain more
insight into the role of proteoglycans in cell division, future
studies should identify the core proteins modified with pro-
teoglycans in oocytes and the early embryo. Also the role of
sulfate modification of the chondroitin or dermatan GAG
chains by sulfotransferases should be explored to help us
understand how negatively charged sugar polymers stabi-
lize the cell membranes during cytokinesis.
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